180 related articles for article (PubMed ID: 32598470)
1. Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan.
Hsu CW; Lee SY; Yang YH; Wang LJ
Int J Neuropsychopharmacol; 2020 Dec; 23(10):653-661. PubMed ID: 32598470
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans.
Vlahiotis A; Devine ST; Eichholz J; Kautzner A
J Manag Care Pharm; 2011 Mar; 17(2):123-32. PubMed ID: 21348545
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of antidepressants on geriatric depression: Real-world evidence from a population-based study.
Hsu CW; Tseng WT; Wang LJ; Yang YH; Kao HY; Lin PY
J Affect Disord; 2022 Jan; 296():609-615. PubMed ID: 34655698
[TBL] [Abstract][Full Text] [Related]
4. The comparative effectiveness of antidepressants for youths with major depressive disorder: a nationwide population-based study in Taiwan.
Lee SY; Wang LJ; Yang YH; Hsu CW
Ther Adv Chronic Dis; 2022; 13():20406223221098114. PubMed ID: 35634571
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan.
Hsu CW; Lee SY; Wang LJ
Schizophr Res; 2018 Mar; 193():107-113. PubMed ID: 28629889
[TBL] [Abstract][Full Text] [Related]
6. Comparative risk of self-harm hospitalization amongst depressive disorder patients using different antidepressants: a population-based cohort study in Taiwan.
Wu CS; Liao SC; Tsai YT; Chang SS; Tsai HJ
Psychol Med; 2017 Jan; 47(1):81-92. PubMed ID: 27659718
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.
Desai RJ; Sarpatwari A; Dejene S; Khan NF; Lii J; Rogers JR; Dutcher SK; Raofi S; Bohn J; Connolly JG; Fischer MA; Kesselheim AS; Gagne JJ
PLoS Med; 2019 Mar; 16(3):e1002763. PubMed ID: 30865626
[TBL] [Abstract][Full Text] [Related]
8. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
Liu YM; Ou HT; Yang YK
J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
[TBL] [Abstract][Full Text] [Related]
9. Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark.
Ishtiak-Ahmed K; Musliner KL; Christensen KS; Mortensen EL; Nierenberg AA; Gasse C
Am J Psychiatry; 2024 Jan; 181(1):47-56. PubMed ID: 37849303
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Switch-to-Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real-World Retrospective Cohort Study.
Kalaria S; Spence O; Hong K; dosReis S; Gopalakrishnan M
Clin Pharmacol Ther; 2021 Aug; 110(2):443-451. PubMed ID: 33811324
[TBL] [Abstract][Full Text] [Related]
11. Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study.
Corrao G; Soranna D; Merlino L; Mancia G
Eur J Clin Invest; 2014 Oct; 44(10):933-9. PubMed ID: 25132063
[TBL] [Abstract][Full Text] [Related]
12. Switching from brand-name to generic psychotropic medications: a literature review.
Desmarais JE; Beauclair L; Margolese HC
CNS Neurosci Ther; 2011 Dec; 17(6):750-60. PubMed ID: 21114789
[TBL] [Abstract][Full Text] [Related]
13. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence.
Gagne JJ; Polinski JM; Jiang W; Dutcher SK; Xie J; Lii J; Fulchino LA; Kesselheim AS
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):944-52. PubMed ID: 27102378
[TBL] [Abstract][Full Text] [Related]
14. Trends in Hospital Visits for Generic and Brand-Name Warfarin Users in Québec, Canada: A Population-Based Time Series Analysis.
Leclerc J; Blais C; Rochette L; Hamel D; Guénette L; Poirier P
Am J Cardiovasc Drugs; 2019 Jun; 19(3):287-297. PubMed ID: 30471054
[TBL] [Abstract][Full Text] [Related]
15. Are generic and brand-name statins clinically equivalent? Evidence from a real data-base.
Corrao G; Soranna D; Arfè A; Casula M; Tragni E; Merlino L; Mancia G; Catapano AL
Eur J Intern Med; 2014 Oct; 25(8):745-50. PubMed ID: 25200803
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the cost and effectiveness of generic and brand-name antibiotics: the case of uncomplicated urinary tract infection.
Lin YS; Jan IS; Cheng SH
Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):301-309. PubMed ID: 27862588
[TBL] [Abstract][Full Text] [Related]
17. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
Borgheini G
Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
[TBL] [Abstract][Full Text] [Related]
18. Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system.
Dunn JD; Cannon E; Mitchell MP; Curtiss FR
J Manag Care Pharm; 2006 May; 12(4):294-302. PubMed ID: 16792435
[TBL] [Abstract][Full Text] [Related]
19. The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysis.
Unterecker S; Proft F; Riederer P; Lauer M; Deckert J; Pfuhlmann B
Ther Drug Monit; 2014 Apr; 36(2):269-72. PubMed ID: 24365982
[TBL] [Abstract][Full Text] [Related]
20. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
